aspenpharma.com

Evaluation du site aspenpharma.com

Aspen Pharmacare | Pharmaceutical Company

 Généré le 12 Mars 2026 17:36

Vieilles statistiques? UPDATE !

Le score est de 57/100

Optimisation du contenu

Titre

Aspen Pharmacare | Pharmaceutical Company

Longueur : 41

Parfait, votre titre contient entre 10 et 70 caractères.

Description

Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets

Longueur : 131

Génial, votre balise META description contient entre 70 et 160 caractères.

Mots-clefs

Très mauvais. Nous n'avons pas trouvé de balise META keywords sur votre page. Utilisez ce générateur gratuit de balises META en ligne pour créer des mots-clés.

Propriétés Open Graph

Bien, cette page profite des balises META Open Graph.

Propriété Contenu
locale en_US
type website
title Aspen Pharmacare | Pharmaceutical Company
description Aspen is a global specialty and branded multinational pharmaceutical company with a presence in both emerging and developed markets
url https://www.aspenpharma.com/
site_name Aspen Pharmacare
image https://www.aspenpharma.com/wp-content/uploads/2023/02/aspen-pharma-vials-home-1.png
image:width 496
image:height 656
image:type image/png

Niveaux de titre

H1 H2 H3 H4 H5 H6
0 62 65 10 60 30
  • [H2] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H2] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H2] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H2] Aspen highlights the rising diabetes disease burden
  • [H2] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H2] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H2] Aspen delivers strong results and advances its strategic ambitions
  • [H2] Aspen announces local availability of Lilly’s Mounjaro
  • [H2] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H2] Aspen to participate in the Investec CEO conference in London
  • [H2] Aspen partners with PinkDrive to mobilise cancer screening
  • [H2] Aspen’s revenue increases 10% underpinned by a strong second half performance
  • [H2] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H2] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H2] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H2] Aspen highlights the rising diabetes disease burden
  • [H2] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H2] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H2] Aspen delivers strong results and advances its strategic ambitions
  • [H2] Aspen announces local availability of Lilly’s Mounjaro
  • [H2] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H2] Aspen to participate in the Investec CEO conference in London
  • [H2] Aspen partners with PinkDrive to mobilise cancer screening
  • [H2] Aspen’s revenue increases 10% underpinned by a strong second half performance
  • [H2] Healthcare. We Care.
  • [H2] Investor Hub
  • [H2] Stephen Saad (61)
  • [H2] Sean Capazorio (60)
  • [H2] Reginald Haman (52)
  • [H2] Kuseni Dlamini 58
  • [H2] Ben Kruger (66)
  • [H2] Linda de Beer (56)
  • [H2] Neo Dongwana (53)
  • [H2] Themba Mkhwanazi (56)
  • [H2] Chris Mortimer (65)
  • [H2] Yvonne Muthien (69)
  • [H2] David Redfern (59)*
  • [H2] Raeesa Khan (35)
  • [H2] Stephen Saad (61)
  • [H2] Gus Attridge (64)
  • [H2] Sean Capazorio (60)
  • [H2] Lorraine Hill (62)
  • [H2] Reginald Haman (51)
  • [H2] Samer Kassem (51)
  • [H2] Pauline Macdonald (49)
  • [H2] Trevor Ziman (54)
  • [H2] Chris Botha (47)
  • [H2] Raeesa Khan (35)
  • [H2] Stavros Nicolaou (60)
  • [H2] Carnie van der Linde (56)
  • [H2] Aspen Key Facts
  • [H2] Latest News
  • [H2] Our Purpose
  • [H2] Our Vision
  • [H2] Our Values
  • [H2] About Aspen
  • [H2] We Care
  • [H2] Careers
  • [H2] Contact Us
  • [H2] Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026. The live presentation will take place in Cape Town at 08h30 on 2 March 2023.
  • [H2] Corporate
  • [H2] View our teams below:
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.
  • [H3] Healthcare. We Care. Excellence Integrity Healthcare. We Care. Innovation Commitment Teamwork
  • [H3] Interim Results Presentation Webcast
  • [H3] FY2026 Interim Results Presentation
  • [H3] FY2026 Interim Results Booklet
  • [H3] FY2026 Interim Results Short Form Announcement
  • [H3] Our Heritage
  • [H3] Fact Sheet
  • [H3] Interim Results Presentation
  • [H3] Illustrative Revenue Disclosure
  • [H3] Interim Results Booklet
  • [H3] Interim Results Booklet – Excel Download
  • [H3] Interim Results Presentation Webcast
  • [H3] Interim Results Short Form Announcement
  • [H3] Stakeholder Update Call Presentation 15 January 2026
  • [H3] Stakeholder Update Call Webcast 15 January 2026
  • [H3] Sustainability and ESG Data Supplement
  • [H3] Social and Ethics Committee Report
  • [H3] Notice of AGM
  • [H3] Integrated Report
  • [H3] Audit & Risk Committee Report
  • [H3] Integrated Report – View Online Version
  • [H3] Carbon Disclosure Project – Climate Change and Water Security
  • [H3] Equity Report – Pharmacare Workforce Profile
  • [H3] IBIS Assurance Statement
  • [H3] Sustainability and ESG Data Supplement
  • [H3] Sustainability Materiality Assessment
  • [H3] Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment
  • [H3] Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion
  • [H3] Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award
  • [H3] Aspen highlights the rising diabetes disease burden
  • [H3] Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
  • [H3] Aspen celebrates 15 years of commitment to Nelson Mandela Day
  • [H3] Aspen delivers strong results and advances its strategic ambitions
  • [H3] Aspen announces local availability of Lilly’s Mounjaro
  • [H3] Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
  • [H3] Aspen to participate in the Investec CEO conference in London
  • [H3] Aspen Ireland gets recognised for their efforts in diversity
  • [H3] Shining the spotlight on trailblazers in Science this International Women’s Day
  • [H3] Aspen North America Region’s Aspen Canada certified as a Great Place to Work®
  • [H3] Aspen continues to demonstrate its unwavering commitment to our various communities
  • [H3] Aspen partners with Reach for a Dream to bring joy to children with rare diseases 
  • [H3] Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status
  • [H3] Aspen recognised for EY Excellence in Integrated Reporting Award
  • [H3] Closed Period
  • [H4] Board of Directors
  • [H4] Group Executive Committee
  • [H4] Financial Results
  • [H4] Integrated Reporting
  • [H4] Sustainability Documents
  • [H4] Interim Results
  • [H4] Additional Presentations and webcasts
  • [H4]  
  • [H4] Annual Financial Statements
  • [H4] Access to Medicines Position Paper
  • [H5] About Aspen
  • [H5] Corporate Governance
  • [H5] Regional Overview
  • [H5] Business Segments
  • [H5] Manufacturing
  • [H5] Investor Relations
  • [H5] Investor Relations
  • [H5] We Care
  • [H5] Ethics & Compliance Management
  • [H5] SED Initiatives
  • [H5] Mandela Day
  • [H5] Our Sustainability Commitments
  • [H5] Careers
  • [H5] High Performing, Inclusive Culture
  • [H5] Working At Aspen
  • [H5] Bursary Applications
  • [H5] Media
  • [H5] Aspen Holding News
  • [H5] About Aspen
  • [H5] Corporate Governance
  • [H5] Regional Overview
  • [H5] Business Segments
  • [H5] Manufacturing
  • [H5] Investor Relations
  • [H5] Investor Relations
  • [H5] We Care
  • [H5] Ethics & Compliance Management
  • [H5] SED Initiatives
  • [H5] Mandela Day
  • [H5] Our Sustainability Commitments
  • [H5] Careers
  • [H5] High Performing, Inclusive Culture
  • [H5] Working At Aspen
  • [H5] Bursary Applications
  • [H5] Media
  • [H5] Aspen Holding News
  • [H5] Stephen Saad(61)
  • [H5] Sean Capazorio(60)
  • [H5] Reginald Haman(52)
  • [H5] Kuseni Dlamini(58)
  • [H5] Ben Kruger(66)
  • [H5] Linda de Beer(56)
  • [H5] Neo Dongwana(53)
  • [H5] Themba Mkhwanazi(56)
  • [H5] Chris Mortimer(65)
  • [H5] Yvonne Muthien(69)
  • [H5] David Redfern(59)
  • [H5] Raeesa Khan(35)
  • [H5] Stephen Saad(61)
  • [H5] Gus Attridge(64)
  • [H5] Sean Capazorio(60)
  • [H5] Lorraine Hill(62)
  • [H5] Reginald Haman(52)
  • [H5] Samer Kassem(51)
  • [H5] Pauline Macdonald(49)
  • [H5] Trevor Ziman(54)
  • [H5] Chris Botha(47)
  • [H5] Raeesa Khan(35)
  • [H5] Stavros Nicolaou(60)
  • [H5] Carnie van der Linde(56)
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Further Information
  • [H6] Responsibilities
  • [H6] Responsibilities
  • [H6] Find out more
  • [H6] To improve the health and quality of life of patients.
  • [H6] Find out more
  • [H6] To deliver value to all our stakeholders as a responsible corporate citizen that provides high-quality, affordable medicines globally.
  • [H6] Find out more
  • [H6] Define the foundation on which Aspen has been built. These are the values we share as we work together toward achieving the vision of the Group.

Images

Nous avons trouvé 91 image(s) sur cette page Web.

51 attribut(s) alt sont vides ou manquants. Ajouter un texte alternatif permet aux moteurs de recherche de mieux comprendre le contenu de vos images.

Ratio texte/HTML

Ratio : 13%

le ratio de cette page texte/HTML est au-dessous de 15 pour cent, ce qui signifie que votre site manque de contenu textuel.

Flash

Parfait, aucun contenu FLASH n'a été détecté sur cette page.

Iframe

Génial, il n'y a pas d'Iframes détectés sur cette page.

Réécriture d'URLs

Bien. Vos liens sont optimisés!

Tiret bas dans les URLs

Parfait! Aucuns soulignements détectés dans vos URLs.

Liens dans la page

Nous avons trouvé un total de 92 lien(s) dont 0 lien(s) vers des fichiers

Texte d'ancre Type Juice
About Aspen Interne Passing Juice
Corporate Governance Interne Passing Juice
Regional Overview Interne Passing Juice
Manufacturing Interne Passing Juice
Interim Results Presentation Webcast Interne Passing Juice
FY2026 Interim Results Presentation Interne Passing Juice
Investor Relations Interne Passing Juice
Careers Interne Passing Juice
Aspen Holding News Interne Passing Juice
Aspen delivers encouraging results, driven by strong Commercial Pharma, reshaped Manufacturing and value realisation from APAC divestment Interne Passing Juice
Proposed divestment of Aspen Asia Pacific (excluding China) for R26.5 billion Interne Passing Juice
Stephen Saad receives both AABLA Lifetime Achievement Award and African of the Year Award Interne Passing Juice
Aspen highlights the rising diabetes disease burden Interne Passing Juice
Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified Interne Passing Juice
Aspen celebrates 15 years of commitment to Nelson Mandela Day Interne Passing Juice
Aspen delivers strong results and advances its strategic ambitions Interne Passing Juice
Aspen announces local availability of Lilly’s Mounjaro Interne Passing Juice
Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day Interne Passing Juice
Aspen to participate in the Investec CEO conference in London Interne Passing Juice
Aspen partners with PinkDrive to mobilise cancer screening Interne Passing Juice
Aspen’s revenue increases 10% underpinned by a strong second half performance Interne Passing Juice
Contact Us Interne Passing Juice
FY2026 Interim Results Booklet Interne Passing Juice
FY2026 Interim Results Short Form Announcement Interne Passing Juice
Fact Sheet Interne Passing Juice
Interim Results Presentation Interne Passing Juice
Illustrative Revenue Disclosure Interne Passing Juice
Interim Results Booklet Interne Passing Juice
Interim Results Booklet – Excel Download Interne Passing Juice
Interim Results Presentation Webcast Interne Passing Juice
Interim Results Short Form Announcement Interne Passing Juice
Stakeholder Update Call Presentation 15 January 2026 Interne Passing Juice
Stakeholder Update Call Webcast 15 January 2026 Interne Passing Juice
Annual Financial Statements Interne Passing Juice
Sustainability and ESG Data Supplement Interne Passing Juice
Social and Ethics Committee Report Interne Passing Juice
Notice of AGM Interne Passing Juice
Integrated Report Interne Passing Juice
Audit & Risk Committee Report Interne Passing Juice
Integrated Report – View Online Version Interne Passing Juice
Access to Medicines Position Paper Interne Passing Juice
Carbon Disclosure Project – Climate Change and Water Security Interne Passing Juice
Equity Report – Pharmacare Workforce Profile Interne Passing Juice
IBIS Assurance Statement Interne Passing Juice
Sustainability Materiality Assessment Interne Passing Juice
Aspen Ireland gets recognised for their efforts in diversity Interne Passing Juice
Shining the spotlight on trailblazers in Science this International Women’s Day Interne Passing Juice
Aspen North America Region’s Aspen Canada certified as a Great Place to Work® Interne Passing Juice
Aspen continues to demonstrate its unwavering commitment to our various communities Interne Passing Juice
Aspen partners with Reach for a Dream to bring joy to children with rare diseases  Interne Passing Juice
Aspen launches its 2025 Integrated Report and retains Level 4 B-BBEE status Interne Passing Juice
Aspen recognised for EY Excellence in Integrated Reporting Award Interne Passing Juice
Disclaimer Interne Passing Juice
General Privacy Notice Externe Passing Juice
Aspen PAIA & POPI Manual Externe Passing Juice
Standard Terms of purchase of goods or services (STC) Externe Passing Juice
Australia Interne Passing Juice
China Externe Passing Juice
New Zealand Externe Passing Juice
Philippines Externe Passing Juice
Austria Externe Passing Juice
France Externe Passing Juice
France – NDB Externe Passing Juice
Netherlands Externe Passing Juice
Netherlands – Oss Externe Passing Juice
Russia Externe Passing Juice
Spain Externe Passing Juice
Switzerland Externe Passing Juice
MENAT Externe Passing Juice
Canada Externe Passing Juice
USA Externe Passing Juice
Brazil Interne Passing Juice
Mexico Externe Passing Juice
Ghana Externe Passing Juice
Kenya Externe Passing Juice
Mauritius Externe Passing Juice
Nigeria Externe Passing Juice
South Africa – SA Commercial Externe Passing Juice
South Africa – FCC Externe Passing Juice
South Africa HQ Externe Passing Juice
Tanzania Externe Passing Juice
EME Externe Passing Juice
France Externe Passing Juice
Germany Externe Passing Juice
Human Capital Interne Passing Juice
Legal Interne Passing Juice
Supply Chain Interne Passing Juice
Treasury Interne Passing Juice
Ethics & Compliance Interne Passing Juice
Risk & Sustainability Interne Passing Juice
Digital Technology Interne Passing Juice
Tax Interne Passing Juice

Mots-clefs

Nuage de mots-clefs

more results executive classification aspen read appointed qualifications business group

Cohérence des mots-clefs

Mot-clef Contenu Titre Mots-clefs Description Niveaux de titre
aspen 61
group 41
more 35
appointed 29
read 27

Ergonomie

Url

Domaine : aspenpharma.com

Longueur : 15

Favicon

Génial, votre site web dispose d'un favicon.

Imprimabilité

Génial. L'impression est optimisée grâce aux styles CSS.

Langue

Bien. Votre langue est : en.

Dublin Core

Cette page ne profite pas des métadonnées Dublin Core.

Document

Doctype

HTML 5

Encodage

Parfait. Votre charset est UTF-8.

Validité W3C

Erreurs : 0

Avertissements : 0

E-mail confidentialité

Génial, aucune adresse e-mail n'a été trouvé sous forme de texte!

HTML obsolètes

Génial! Nous n'avons pas trouvé de balises HTML obsolètes dans votre code.

Astuces vitesse

Excellent, votre site n'utilise pas de tableaux imbriqués.
Mauvais, votre site web utilise des styles css inline.
Mauvais, votre site web contient trop de fichiers CSS (plus de 4).
Mauvais, votre site web contient trop de fichiers javascript (plus de 6).
Parfait : votre site tire parti de gzip.

Mobile

Optimisation mobile

Icône Apple
Méta tags viewport
Contenu FLASH

Optimisation

Sitemap XML

Votre site web dispose d’une sitemap XML, ce qui est optimal.

https://www.aspenpharma.com/sitemap_index.xml

Robots.txt

https://aspenpharma.com/robots.txt

Votre site dispose d’un fichier robots.txt, ce qui est optimal.

Mesures d'audience

Manquant

Nous n'avons trouvé aucun outil d'analytics sur ce site.

Un outil de mesure d'audience vous permet d'analyser l’activité des visiteurs sur votre site. Vous devriez installer au moins un outil Analytics. Il est souvent utile d’en rajouter un second, afin de confirmer les résultats du premier.

PageSpeed Insights

Dispositif
Les catégories

Free SEO Testing Tool

Free SEO Testing Tool est un outil gratuit de référencement qui vous aidera à analyser vos pages web